We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-18.84%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
AUM
$189M
AUM Growth
-$35.6M
Cap. Flow
+$958K
Cap. Flow %
0.51%
Top 10 Hldgs %
53.49%
Holding
84
New
11
Increased
22
Reduced
15
Closed
36

Sector Composition

Rank Sector Weight
1 Healthcare 91.46%
2 Industrials 3.75%
3 Technology 3.46%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$15.9M 8.41%
119,071
+40,551
+52% +$6.65M
CI icon
2
Cigna
CI
$73.7B
$13.5M 7.12%
70,944
-11,870
-14% -$2.48M
ZBH icon
3
Zimmer Biomet
ZBH
$18.2B
$12.9M 6.79%
127,622
+86,871
+213% +$9.77M
CELG
4
DELISTED
Celgene Corp
CELG
$10.8M 5.71%
168,609
+70,208
+71% +$5.18M
CVS icon
5
CVS Health
CVS
$133B
$9.67M 5.11%
147,629
+56,211
+61% +$4.2M
MDT icon
6
Medtronic
MDT
$109B
$8.44M 4.46%
92,827
+27,698
+43% +$2.59M
SHPG
7
DELISTED
Shire pic
SHPG
$8.02M 4.24%
46,100
-44,043
-49% -$7.7M
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
$7.68M 4.06%
282,108
-25,108
-8% -$694K
DVA icon
9
DaVita
DVA
$15.4B
$7.24M 3.83%
140,729
+70,639
+101% +$4.52M
RCM
10
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.1M 3.75%
893,421
+425,958
+91% +$3.68M
IIN
11
DELISTED
IntriCon Corporation
IIN
$6.54M 3.46%
247,980
+212,486
+599% +$8.08M
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$5.89M 3.12%
461,234
+166,005
+56% +$2.52M
MDRX
13
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.7M 3.01%
591,533
+515,039
+673% +$5.74M
HOLX
14
DELISTED
Hologic
HOLX
$5.58M 2.95%
135,805
+42,760
+46% +$1.75M
ICLR icon
15
Icon
ICLR
$12.6B
$5.32M 2.81%
41,132
+25,033
+155% +$3.46M
EHC icon
16
Encompass Health
EHC
$11B
$5.26M 2.78%
+107,187
New +$6.1M
XRAY icon
17
Dentsply Sirona
XRAY
$2.68B
$4.41M 2.33%
+118,424
New +$4.31M
UNH icon
18
UnitedHealth
UNH
$376B
$4.17M 2.2%
16,732
+9,810
+142% +$2.59M
SNY icon
19
Sanofi
SNY
$103B
$3.53M 1.87%
81,401
-51,844
-39% -$2.29M
PODD icon
20
Insulet
PODD
$11.5B
$3.23M 1.71%
+40,727
New +$3.45M
BHC icon
21
Bausch Health
BHC
$2.58B
$3.03M 1.6%
163,908
-533
-0.3% -$12.7K
IOVA icon
22
Iovance Biotherapeutics
IOVA
$1.82B
$2.82M 1.49%
318,185
+76,016
+31% +$733K
BMY icon
23
Bristol-Myers Squibb
BMY
$133B
$2.56M 1.36%
49,337
-28,634
-37% -$1.54M
SRPT icon
24
Sarepta Therapeutics
SRPT
$1.57B
$2.36M 1.25%
21,615
+13,159
+156% +$1.65M
NVRO
25
DELISTED
NEVRO CORP.
NVRO
$2.14M 1.13%
54,977
+30,806
+127% +$1.37M

Similar funds

Endurant Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Endurant Capital Management held 84 positions worth $189M, down 16% from $225M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Endurant Capital Management's Q4 2018 filing shows 11 new, 22 increased, 15 reduced and 36 closed positions. Its largest new stake was Encompass Health: 107,187 shares worth $5.26M. The largest sale was Tivity Health, Inc. Common Stock, an estimated $9.99M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 93% a quarter earlier, followed by Industrials and Technology.

  • Endurant Capital Management's largest Q4 2018 buy was Encompass Health: 107,187 shares worth $5.26M.
  • Endurant Capital Management added most to Zimmer Biomet in Q4 2018, an estimated $9.77M increase.
  • Endurant Capital Management's biggest Q4 2018 reduction was Shire pic, cutting an estimated $7.7M.
  • Endurant Capital Management fully exited Tivity Health, Inc. Common Stock in Q4 2018, selling an estimated $9.99M.
  • Endurant Capital Management's ten largest holdings make up 53% of its $189M portfolio in Q4 2018.
  • Endurant Capital Management opened 11 new positions and closed 36 in Q4 2018.
  • Endurant Capital Management's portfolio value fell 16% quarter-over-quarter to $189M.

Based on Endurant Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.